Cartesian Therapeutics Statistics
Total Valuation
RNAC has a market cap or net worth of $373.91 million. The enterprise value is $307.95 million.
| Market Cap | 373.91M |
| Enterprise Value | 307.95M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, before market open.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RNAC has 17.78 million shares outstanding. The number of shares has increased by 6.33% in one year.
| Shares Outstanding | 17.78M |
| Shares Change (YoY) | +6.33% |
| Shares Change (QoQ) | +2.60% |
| Owned by Insiders (%) | 61.39% |
| Owned by Institutions (%) | 12.34% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 25.45 |
| PS Ratio | 14.38 |
| Forward PS | 43.99 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.33
| Current Ratio | 1.33 |
| Quick Ratio | 1.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -83.26 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -124.40% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $702,811 |
| Profits Per Employee | -$5.94M |
| Employee Count | 37 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -19.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.09% in the last 52 weeks. The beta is 0.83, so RNAC's price volatility has been lower than the market average.
| Beta (1Y) | 0.83 |
| 52-Week Price Change | -40.09% |
| 50-Day Moving Average | 19.27 |
| 200-Day Moving Average | 26.98 |
| Relative Strength Index (RSI) | 59.96 |
| Average Volume (30 Days) | 52,580 |
Short Selling Information
The latest short interest is 638,538, so 3.59% of the outstanding shares have been sold short.
| Short Interest | 638,538 |
| Short Previous Month | 8.79M |
| Short % of Shares Out | 3.59% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.16 |
Income Statement
In the last 12 months, RNAC had revenue of $26.00 million and -$219.71 million in losses. Loss per share was -$49.80.
| Revenue | 26.00M |
| Gross Profit | 26.00M |
| Operating Income | -86.42M |
| Pretax Income | -238.71M |
| Net Income | -219.71M |
| EBITDA | -233.28M |
| EBIT | -235.88M |
| Loss Per Share | -$49.80 |
Balance Sheet
The company has $76.91 million in cash and $10.96 million in debt, giving a net cash position of $65.96 million or $3.71 per share.
| Cash & Cash Equivalents | 76.91M |
| Total Debt | 10.96M |
| Net Cash | 65.96M |
| Net Cash Per Share | $3.71 |
| Equity / Book Value | -440.18M |
| Book Value Per Share | -24.76 |
| Working Capital | 22.52M |
Cash Flow
In the last 12 months, operating cash flow was -$51.16 million and capital expenditures -$206,000, giving a free cash flow of -$51.37 million.
| Operating Cash Flow | -51.16M |
| Capital Expenditures | -206,000 |
| Free Cash Flow | -51.37M |
| FCF Per Share | -$9.94 |
Margins
Gross margin is 100.00%, with operating and profit margins of -332.32% and -844.91%.
| Gross Margin | 100.00% |
| Operating Margin | -332.32% |
| Pretax Margin | -917.97% |
| Profit Margin | -844.91% |
| EBITDA Margin | -897.09% |
| EBIT Margin | -907.08% |
| FCF Margin | -197.53% |
Dividends & Yields
RNAC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.33% |
| Shareholder Yield | -6.33% |
| Earnings Yield | -58.76% |
| FCF Yield | -13.74% |
Analyst Forecast
The average price target for RNAC is $27.67, which is 31.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.67 |
| Price Target Difference | 31.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 5, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Apr 5, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
RNAC has an Altman Z-Score of -4.69 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.69 |
| Piotroski F-Score | 2 |